Skip to main content
Erschienen in: BMC Medical Research Methodology 1/2019

Open Access 01.12.2019 | Research article

Analysis of reporting completeness in exercise cancer trials: a systematic review

verfasst von: Jose Francisco Meneses-Echavez, Indira Rodriguez-Prieto, Mark Elkins, Javier Martínez-Torres, Lien Nguyen, Julia Bidonde

Erschienen in: BMC Medical Research Methodology | Ausgabe 1/2019

Abstract

Background

Exercise is an effective therapeutic intervention for cancer survivors. Concerns about the completeness of reporting of exercise interventions have been raised in the literature, but without any formal analysis. This study aimed to evaluate the completeness of reporting of exercise interventions for cancer survivors in a large sample of randomized clinical trials (RCTs).

Methods

We developed a pre-defined protocol. We searched MEDLINE, EMBASE, and CENTRAL for exercise trials in oncology between 2010 and 2017. Pairs of independent researchers screened the records, extracted study characteristics, and assessed 16 items on the TIDieR checklist (i.e., the 12 items, with item 5 divided into two and item 8 divided into four). For each of these items, the percentage of interventions in the included studies that reported the item was calculated.

Results

We included 131 RCTs reporting 138 interventions in the analysis. Breast cancer was the most common type of cancer (69, 50%), and aerobic exercise was the most studied exercise modality (43, 30%) followed by combined aerobic and resistance training (40, 28%). Completeness of reporting ranged from 42 to 96% among the TIDieR items; none of the items was fully reported. ‘Intervention length’ was the most reported item across interventions (133, 96%), followed by ‘rationale’ (131, 95%), whereas ‘provider’ (58, 42%) and ‘how well (planned)’ (63, 46%) were the two least reported items. Half of the TIDieR items were completely reported in 50 to 70% of the interventions, and only four items were reported in more than 80% of the interventions (Items 2 and 8a to c). The seven items deemed to be core for replication (Items 3 to 9) exhibited a mean reporting of 71%, ranging from 42 to 96%.

Conclusion

Exercise training interventions for cancer survivors are incompletely reported across RCTs published between 2010 and 2017. The reporting of information about the provider, materials, and modifications require urgent improvements. Stronger reporting will enhance usability of trial reports by both healthcare providers and survivors, and will help to reduce research waste.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12874-019-0871-0.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CERT
Consensus on Exercise Reporting Template
CONSORT
Consolidated Standards of Reporting Trials
CReDECI 2
Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare
PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RCT
Randomized Clinical Trial
SPIRIT
Standard Protocol Items: Recommendations for Interventional Trials
TIDieR
Template for Intervention Description and Replication

Background

Exercise is recognized as one of the most effective non-pharmacological interventions for improving outcomes for cancer survivors [1]. A strong body of evidence suggests that cancer survivors who exercise gain benefits in quality of life, fatigue, mobility [2], depression, post-operative outcomes [3], and the tumor microenvironment [4, 5]. The first report of the American Cancer Society about exercise and cancer was published in 2003 [6]; and since then, the number of randomized clinical trials (RCTs) addressing the effects of exercise in cancer survivors has grown exponentially.
The rapid accumulation of RCTs of exercise in cancer survivors should improve clinical outcomes, but only if the exercise interventions are reported thoroughly. Incomplete reporting of the exercise interventions impedes clinicians', researchers' and patients’ use of the evidence [710]. Incomplete reporting of interventions can also impair the synthesis of evidence (i.e. systematic reviews) in several ways [11, 12]: trials may be erroneously included or excluded because of uncertainty about the intervention; and treatment differences may go unrecognized as a source of between-study variation in effect estimates. By impairing systematic reviews, clinical decision-making is also affected [13, 14].
Complete reporting of interventions encompasses more than just naming or labelling the intervention and listing its main components; researchers must report also on other key features of the interventions, such as duration, intensity/dose, setting, mode of delivery, and monitoring [8, 9, 15, 16]. Reporting the rationale/framework underlying the intervention may aid clinicians to adjust it to suit the comorbidities or other characteristics of individual patients.
The completeness of reporting is generally lower in non-pharmacological than in pharmacological trials [8]. In reviews of trials of exercise in cancer survivors, various research groups have expressed concern about the description of the exercise protocols [1, 17, 18]. We found similar examples in the literature. In one review, only 39% of the non-pharmacological trials provided complete data for the intervention details [9]. In a review of supervised exercise training in people with peripheral arterial disease, only around one-quarter of the trials described complete data for the mode of exercise, intensity of exercise, and tailoring/progression; and around one-tenth reported exercise intensity comprehensively [19]. Similar findings were found on exercise-based cardiac rehabilitation trials [20]. The study by Candy on complex interventions in education and psychotherapies [21], concluded there was “no overall evidence that reporting the specifics of multicomponent, non-pharmacological interventions is improving”. In addition, Candy mentioned, “details to replicate interventions remain lacking, impairing best implementation or meaningful further research” [21].
In order to assess the completeness of reporting, various checklists have been developed; for example the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement for use at the protocol stage [22] and the CONSORT (Consolidated Standards of Reporting Trials) for pharmacological [23] and non-pharmacological treatments [24] at the manuscript stage. The TIDieR (template for intervention description and replication) tool was published as an extension to the above documents, to increase the detail reported about interventions [25]. The checklist contains 12 items: name, why, what, who provided, how, where, when and how much, tailoring, modifications, how well, adherence and fidelity [25]. Authors conducting intervention RCTs are encouraged to use the TIDieR checklist to enable replication and facilitate the potential impact of their research on both health and society [25].
To our knowledge, no formal analysis has been published in the cancer and exercise field. The present study aimed to evaluate the completeness of reporting of exercise training interventions in RCTs that test exercise interventions in cancer survivors, using items on the TIDieR checklist.

Methods

This study is reported according to the PRISMA statement [26] and the guidelines for reporting meta-epidemiological methodology research [27]. We developed the protocol a priori and made it available via Open Science Framework (https://​osf.​io/​6ejh9/​?​view_​only=​4320d9fbe4134ca8​8422d1eaf3d5b44a​; DOI https://​doi.​org/​10.​17605/​OSF.​IO/​6EJH9). We present amendments made to the protocol in Additional file 1.

Search strategy and screening

An information specialist (LN) designed, tested and implemented a systematic search for RCTs published in the MEDLINE, EMBASE, and CENTRAL databases between 2010 and 2017. We selected 2010 because of the most recent update of the CONSORT statement [23], which was launched in 2010. One reviewer (JME) screened the reference lists of relevant systematic reviews in the field. Additional file 2 presents the search strategies for MEDLINE, EMBASE and CENTRAL. We used the management software Rayyan [28] for independent screening of title and abstract. Pairs of researchers discussed disagreements, with resolution by an independent third researcher when necessary. Figure 1 presents the flow of information through the different phases of a systematic review.

Selection criteria

We included RCTs meeting the following criteria:

Population

Adult (older than 18 years old) survivors of any type of cancer. A survivor was defined according to the Centers for Disease Control and Prevention (CDC), as anyone who has been diagnosed with cancer, from the time of diagnosis through the rest of life [29].

Intervention

RCTs evaluating the effects of exercise training interventions for cancer survivors. Exercise training was defined as any body movement that increases energy expenditure and that is planned, structured, repetitive, and purposive in the sense that it aims to improve or maintain one or more components of physical fitness (i.e., cardiorespiratory endurance, muscular endurance, muscular strength, body composition, and flexibility) [30, 31].
We accepted for inclusion any exercise training interventions involving different training modes, such as aerobic, resistance and flexibility training, as well as yoga, Qi-gong and Tai-Chi [32, 33]. Further, the exercise training interventions could be conducted in different settings (such as clinical or community) or mediums (such as water or land). Because of the review’s focus on the reporting of exercise training interventions, we excluded RCTs that evaluated recreational physical activity interventions, as well as trials reporting on manual therapy (e.g., joint mobilization techniques and therapeutic massage), cognitive-behavioral interventions, and mixed interventions that combined exercise with other therapeutic approaches, such as psychotherapy or diet or dietary advice/counseling. Finally, we excluded trials that compared exercise training with pharmacological and surgical treatments.

Comparison

We included studies with non-exercise intervention comparisons (such as conventional care) or other exercise interventions (e.g., aerobic versus resistance training). Where trials compared two exercise interventions, both interventions were included in the analysis.

Study design and type of publication

We included RCTs. If there was any dispute about the eligibility of a trial’s design, we referred to the National Cancer Institute’s definition [34]. Only full-text publications were included in the review. As we included studies and not research papers, when multiple publications from a single RCT were found, authors decided to use the primary publication for this analysis. We made this decision to avoid double counting of studies and for practical reasons.

Language

We considered for inclusion studies published in languages the team could translate i.e. English, Spanish, Italian, Portuguese and Scandinavian languages.

Data extraction and management

Characteristics of the included studies

We extracted the following information: publication year, country, trial registry, study name, primary publication/companion, sample size (total analyzed), type of cancer, treatment stage, control group(s), exercise mode, length (weeks, with the minimum value reported in case of range), frequency (sessions/week), and setting. Walking interventions were classified as aerobic exercise.

TIDieR checklist and calculation of completeness of reporting

A pair of researchers (JME, JB, IR, JMT) worked independently to apply the TIDieR checklist to the included RCTs. As recommended by the TIDieR committee, the checklist is completed following the TIDieR guide [25], which contains an explanation and elaboration for each item. All the items were rated Yes/No. Only items that were clearly met were rated Yes; any that were partially met were rated No. Pairs of researchers discussed disagreements, with those outstanding resolved by an independent third researcher. Item 5 contributed two components and Item 8 contributed four components. See Table 1.
Table 1
Final version of the TIDieR checklist used in this study (16 items)
1. Brief name
Provide the name or a phrase that describes the intervention
2. Why
Describe any rationale, theory, or goal of the elements essential to the intervention
3. What (Materials)
Describe any physical or informational materials used in the intervention
4. What (procedures)
Describe each of the procedures, activities, and/or processes used in the intervention
5. a. Who provided (disciplinary background)
Describe the disciplinary background of the provider
b. Who provided (expertise, experience, or specific training)
Describe the expertise, experience, or specific training of the provider
6. How
Describe the modes of delivery
7. Where
Describe the type(s) of location(s) where the intervention occurred
8. a. When and how much (frequency)
Describe the number of times the intervention was delivered (e.g., number of sessions)
b. When and how much (length)
Describe the number of weeks/months the intervention lasted
c. When and how much (duration)
Describe the duration of each session (e.g., minutes /session)
d. When and how much (intensity)
Describe the intensity at which the exercise was practiced
9. Tailoring
If the intervention was planned to be personalized, titrated or adapted, then describe what, why, when, and how
10. Modifications
If the intervention was modified during the course of the study, describe the changes
11. How well (planned)
If intervention adherence or fidelity was assessed, describe how and by whom, and if any strategies were used to maintain or improve fidelity, describe them.
12. How well (actual)
If intervention adherence or fidelity was assessed, describe the extent to which the intervention was delivered as planned.

Overall and subgroup analyses

For each of these items, the percentage of interventions in the included studies that reported the item was calculated. We presented separate data for the subgroups of breast cancer and non-breast cancer trials, and exercise modality.

Results

The systematic searches yielded 10,702 records, and 28 additional records were found by hand searching systematic reviews in this field. After removal of duplicates, we exported 6862 records to Rayyan for screening of title and abstract, after which we read 328 records as full-text manuscripts. One reviewer (JME) retrieved all full-text publications. We included 131 RCTs in our analysis.

Characteristics of the included studies

The 131 RCTs contributed information about 138 interventions to the analysis. The characteristics of the individual included studies/interventions such as country, year of publication, sample size, type of cancer reported, treatment stage, and other are presented in Additional file 3. Summary data are presented below.
Twenty-one trials (16%) provided study name or acronym, and forty-four (34%) reported their trial registry record/trial protocol. Hereafter we refer to interventions (rather than trials) as they represent our unit of analysis.
Overall, we report data from 38 countries. USA was the most common country across the analyzed interventions (38, 27%), followed by Australia (17, 12%), Canada (12, 9%), Germany (11, 8%), Korea (6, 4%), and Spain (5, 4%). Around half of the interventions were performed in groups of 10 to 50 participants (65, 47%), and one-third included 51 to 100 participants (47, 34%). Breast cancer was the most common type of cancer (69, 50%), followed by prostate cancer (20, 14%), mixed (more than one type) (14, 10%), and colorectal cancer (7, 5%). Most exercise interventions were administered to people receiving active cancer treatment (71, 51%), followed by post-treatment administration (62, 45%) and pre-operative administration (6, 4%).

Interventions: exercise modalities

Aerobic exercise was the most studied exercise modality (43, 30%) followed by combined aerobic/resistance training (40, 28%). Resistance training alone and yoga accounted for around 13% of the interventions each. Other modalities comprised Qigong, aquatic exercise, football, high-intensity training, and Tai-Chi. One-third of the exercise interventions were implemented in clinics or hospitals. On average, exercise interventions lasted 14.3 weeks (range 1 to 104 weeks), and involved 2.8 (range 1 to 14) sessions per week.

Completeness of reporting of the exercise training interventions

Total sample

Completeness of reporting ranged from 42 to 96% among the TIDieR items (see Fig. 2). Intervention length was the most reported item across interventions (133, 96%), followed by study rationale (131, 95%), whereas provider (58, 42%) and how well (planned) item (63, 46%) were the two least reported items. Half of the TIDieR items were reported in 50 to 70% of the interventions, and only four items were reported in more than 80% of the interventions (items 2 and 8a-c). In addition, the seven items [39] deemed to be core for replication [25] exhibited a mean reporting of 71%, ranging from 42 to 96%.

Subgroup analysis 1: breast cancer

Breast cancer exercise-training interventions counted for half of the total sample in this study. However, completeness of reporting among the interventions exhibited similar results to the total sample. The largest difference was a 17% less complete reporting of item 7 (where) than in the non-breast cancer subgroup. See Table 2.
Table 2
Completeness of reporting of the exercise interventions: total sample and type of cancer subgroups
TIDieR item
Total sample
n (%)
Breast cancer
n (%)
Non-breast cancer
n (%)
Item 1. Brief name
76 (55%)
36 (52%)
40 (58%)
Item 2. Why
131 (95%)
66 (96%)
65 (94%)
Item 3. What (materials)
81 (59%)
40 (58%)
41 (59%)
Item 4. What (procedures)
108 (78%)
53 (77%)
55 (80%)
Item 5a. Who provided (disciplinary background)
93 (67%)
44 (64%)
49 (71%)
Item 5b. Who provided (expertise, experience, or specific training)
58 (42%)
30 (44%)
28 (41%)
Item 6. How
104 (75%)
54 (78%)
50 (72%)
Item 7. Where
92 (67%)
40 (58%)
52 (75%)
Item 8a. Frequency
123 (89%)
60 (87%)
63 (91%)
Item 8b. Length
133 (96%)
66 (96%)
67 (97%)
Item 8c. Duration
120 (87%)
63 (91%)
57 (83%)
Item 8d. Intensity
90 (65%)
39 (56%)
51 (74%)
Item 9. Tailoring
82 (59%)
37 (54%)
45 (65%)
Item 10. Modifications
70 (51%)
32 (46%)
38 (55%)
Item 11. How well (planned)
63 (46%)
30 (43%)
33 (48%)
Item 12. How well (actual)
70 (51%)
35 (51%)
35 (51%)

Subgroup analysis 2: non-breast cancer

The other half of the interventions, those that involved non-breast cancer patients, comprised predominantly prostate cancer (20, 29%), followed by mixed type and lung cancers (each 14, 20%), and colorectal cancer (7, 10%). In general, this subgroup was reported in a more complete manner than the breast cancer subgroup and the total sample. Only a few items showed lower scores of complete reporting relative to the other groups (Item 2, item 5b, item 6, and item 8c). See Table 2.

Subgroup analysis 3: exercise modality

Overall, aerobic exercise plus resistance training interventions had the lowest level of reporting relative to the other two subgroups (i.e., aerobic exercise and resistance training). Item 2 (why), item 8a (frequency), and item 8b (length) were completely reported in more than 90% of the interventions in all three subgroups. The last two items (items 8 a and b) reached 100% reporting in resistance training interventions. Item 5b (who provided, expertise) was the least reported item across the subgroups. See Table 3.
Table 3
Completeness of reporting of by exercise modality: aerobic exercise; aerobic exercise plus resistance training; resistance training
TIDieR item
Aerobic exercise (n = 43)
Aerobic exercise plus resistance training
(n = 40)
Resistance training
(n = 18)
 
n (%)
n (%)
n (%)
Item 1. Brief name
31 (72.1%)
18 (45%)
10 (55.6%)
Item 2. Why
40 (93%)
37 (92.5%)
18 (100%)
Item 3. What (materials)
29 (67.4%)
17 (42.5%)
11 (61.1%)
Item 4. What (procedures)
34 (79.1%)
29 (72.5%)
16 (88.9%)
Item 5a. Who provided (disciplinary background)
32 (74.4%)
20 (50%)
10 (55.6%)
Item 5b. Who provided (expertise. experience. or specific training)
17 (39.5%)
12 (30%)
5 (27.8%)
Item 6. How
31 (72.1%)
26 (65%)
13 (72.2%)
Item 7. Where
35 (81.4%)
23 (57.5%)
10 (55.6%)
Item 8a. Frequency
40 (93%)
36 (90%)
18 (100%)
Item 8b. Length
40 (93%)
38 (95%)
18 (100%)
Item 8c. Duration
37 (86%)
32 (80%)
16 (88.9%)
Item 8d. Intensity
35 (81.4%)
34 (85%)
14 (77.8%)
Item 9. Tailoring
29 (67.4%)
23 (57.5%)
14 (77.8%)
Item 10. Modifications
15 (34.9%)
21 (53.8%)
15 (83.3%)
Item 11. How well (planned)
20 (46.5%)
18 (46.2%)
10 (55.6%)
Item 12. How well (actual)
24 (55.8%)
15 (39.5%)
12 (66.7%)

Discussion

Main findings

This study evaluated the completeness of reporting of exercise training interventions in a sample of RCTs in cancer survivors. Findings revealed none of the TIDieR items was fully reported across all the interventions in the RCTs. Intervention length and study rationale were the two most reported items. Conversely, relevant information for researchers, healthcare providers, and patients (such as the expertise, experience, or specific training of the provider) obtained the lowest score of reporting. We observed no major differences in the subgroups of breast cancer and non-breast cancer trials, but aerobic exercise and resistance training interventions had the lowest level of reporting compared to the groups of aerobic exercise and resistance training.

Comparison with previous studies

To our knowledge, this is the first study addressing the completeness of reporting in exercise trials involving cancer patients, by using the TIDieR checklist. Other studies have applied TIDieR to exercise trials in people with peripheral arterial disease (58 trials, reporting on 76 interventions) [19], trials on exercise-based cardiac rehabilitation (57 trials, reporting on 74 interventions) [20], and in trials of upper limb therapies for children with unilateral cerebral palsy (60 trials, reporting on 68 interventions) [35]. In the field of exercise and cancer, Neil-Sztramko and collaborators have recently conducted relevant work about the reporting of the components and principles of resistance training prescription in breast cancer trials that measured physical fitness or body composition outcomes [36]. That study found that no trials reported all components of the exercise prescription in the methods, or adherence to the prescribed intervention in the results. Similar findings were found in prostate cancer trials [37].

Strengths and weaknesses

The systematic search run for this study as well as the independent and duplicate conduct of the study selection and data extraction processes constitute methodological strengths. The large number of RCTs evaluated represent the largest study in using the TIDieR checklist to date. Moreover, the research team comprised a journal editor, healthcare providers, and experts in evidence synthesis in the area of exercise in cancer and other chronic conditions. We believe the decision of splitting the number of TIDieR items in our analysis provides a more specific insight to readers interested in this field. The developers of the TIDieR tool supported this approach.
In the event of a single study being reported in multiple publications we chose the primary publication for our analysis. This decision may be a limitation as more complete reporting could have been included in the companion articles. We did this for pragmatic reasons and because we think it is reasonable to expect that the intervention is thoroughly described in the primary report of the study.

Implications for practice and further research

Findings from this study encourage researchers to adhere to international reporting guidance when formulating and publishing their research in order to facilitate translations of their findings into practice. Our results indicate there is still work to be done in this regard. A better reporting of exercise interventions facilitates evidence uptake by clinicians, patients and decision-makers. Besides, a complete reporting of exercise interventions and further research on the reporting of research is one of the key strategies in the battle against research waste [8, 38, 39]. As recently stated by Glasziou and colleagues [39], “unless research is adequately reported, the time and resources invested in the conduct of research is wasted.”
Another purported benefit of reporting checklists such as TIDieR is that they facilitate replication. Further research could examine original and replication trials to determine the completeness of reporting and the faithfulness of the replication.
Future research could examine the reporting of some additional items, some of which have more recently been listed in the Consensus on Exercise Reporting Template (CERT) tool [40]. These factors include whether the exercise is supervised and whether motivational strategies are used. We did not know about the CERT tool at the time our study protocol was formulated, and decided that it was not worth changing the study protocol to incorporate the CERT a posteriori, because of the substantial overlap between it and TIDieR. Another reporting guideline of interest to health professionals in this area is CReDECI 2 (Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare) [41], which focus on complex interventions. Although not all cancer exercise interventions are complex [42], the CReDECI guidelines may provide an alternative checklist for reporting of experimental studies.
Journals should encourage trial authors to adhere to reporting guidance when processing submissions. Thus, journals should endorse checklists for reporting interventions as they do for CONSORT or any other related statements [25]. Hopewell et al. [43] found in a time series design that an active implementation of the CONSORT for abstracts guidelines by journals improved the number of checklist items reported in abstracts of randomized trials. Journals might ask researchers to use TIDieR and perhaps CERT in conjunction when completing item 5 of the CONSORT checklist, and there refer the reader to a detailed assessment of the intervention-reporting checklist.

Conclusion

Exercise training interventions for cancer survivors are reported moderately well among RCTs published between 2010 and 2017. The reporting of information about the provider, materials, and modifications requires urgent improvement. More complete reporting of exercise training interventions for cancer patients will enhance trial usability for both healthcare providers and patients, and will contribute to a large extent in the battle to reduce research waste. Researchers might use the TIDieR checklist when reporting their exercise interventions in further trials.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12874-019-0871-0.

Acknowledgements

We thank Dr. Tammy C Hoffmann for her insight and suggestions regarding the generation of a score of reporting completeness based on the TIDieR checklist.
Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Young-McCaughan S, Arzola S. Exercise intervention research for patients with cancer on treatment. Semin Oncol Nurs. 2007;23(4):264–74.PubMedCrossRef Young-McCaughan S, Arzola S. Exercise intervention research for patients with cancer on treatment. Semin Oncol Nurs. 2007;23(4):264–74.PubMedCrossRef
2.
Zurück zum Zitat Dennett A, Peiris C, Shields N, Prendergast L, Taylor N. Moderate-intensity exercise reduces fatigue and improves mobility in cancer survivors: a systematic review and meta-regression. J Phys. 2016;62(2):68–82. Dennett A, Peiris C, Shields N, Prendergast L, Taylor N. Moderate-intensity exercise reduces fatigue and improves mobility in cancer survivors: a systematic review and meta-regression. J Phys. 2016;62(2):68–82.
3.
Zurück zum Zitat Granger CL. Physiotherapy management of lung cancer. J Phys. 2016;62(2):60–7. Granger CL. Physiotherapy management of lung cancer. J Phys. 2016;62(2):60–7.
4.
Zurück zum Zitat Meneses-Echavez JF, Correa-Bautista JE, Gonzalez-Jimenez E, Schmidt Rio-Valle J, Elkins MR, Lobelo F, et al. The effect of exercise training on mediators of inflammation in breast Cancer survivors: a systematic review with meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1009–17.CrossRef Meneses-Echavez JF, Correa-Bautista JE, Gonzalez-Jimenez E, Schmidt Rio-Valle J, Elkins MR, Lobelo F, et al. The effect of exercise training on mediators of inflammation in breast Cancer survivors: a systematic review with meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1009–17.CrossRef
5.
Zurück zum Zitat Meneses-Echávez JF, Jiménez EG, Río-Valle JS, Correa-Bautista JE, Izquierdo M, Ramírez-Vélez R. The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis. BMC Cancer. 2016;16(1):682.PubMedPubMedCentralCrossRef Meneses-Echávez JF, Jiménez EG, Río-Valle JS, Correa-Bautista JE, Izquierdo M, Ramírez-Vélez R. The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis. BMC Cancer. 2016;16(1):682.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Brown JK, Byers T, Doyle C, Coumeya KS, Demark-Wahnefried W, Kushi LH, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2003;53(5):268–91.PubMedCrossRef Brown JK, Byers T, Doyle C, Coumeya KS, Demark-Wahnefried W, Kushi LH, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2003;53(5):268–91.PubMedCrossRef
7.
Zurück zum Zitat Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. The Lancet. 2009;374(9683):86–9.CrossRef Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. The Lancet. 2009;374(9683):86–9.CrossRef
8.
Zurück zum Zitat Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ (Clinical research ed). 2008;336(7659):1472–4.CrossRef Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ (Clinical research ed). 2008;336(7659):1472–4.CrossRef
9.
Zurück zum Zitat Hoffmann TC, Erueti C, Glasziou PP. Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ Clinical research ed. 2013;347:f3755.PubMedPubMedCentral Hoffmann TC, Erueti C, Glasziou PP. Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ Clinical research ed. 2013;347:f3755.PubMedPubMedCentral
10.
Zurück zum Zitat Li J, Liu Z, Chen R, Hu D, Li W, Li X, et al. The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012. BMC Complement Altern Med. 2014;14:362.PubMedPubMedCentralCrossRef Li J, Liu Z, Chen R, Hu D, Li W, Li X, et al. The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012. BMC Complement Altern Med. 2014;14:362.PubMedPubMedCentralCrossRef
11.
12.
Zurück zum Zitat Vucic K, Jelicic Kadic A, Puljak L. Survey of Cochrane protocols found methods for data extraction from figures not mentioned or unclear. J Clin Epidemiol. 2015;68(10):1161–4.PubMedCrossRef Vucic K, Jelicic Kadic A, Puljak L. Survey of Cochrane protocols found methods for data extraction from figures not mentioned or unclear. J Clin Epidemiol. 2015;68(10):1161–4.PubMedCrossRef
13.
Zurück zum Zitat Group GW. Grading quality of evidence and strength of recommendations. BMJ : British Medical Journal. 2004;328(7454):1490.CrossRef Group GW. Grading quality of evidence and strength of recommendations. BMJ : British Medical Journal. 2004;328(7454):1490.CrossRef
14.
Zurück zum Zitat Harter M, Simon D. Shared decision-making in diverse health care systems--translating research into practice. Patient Educ Couns. 2008;73(3):399–401.PubMedCrossRef Harter M, Simon D. Shared decision-making in diverse health care systems--translating research into practice. Patient Educ Couns. 2008;73(3):399–401.PubMedCrossRef
15.
Zurück zum Zitat Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement Jama. 1996;276(8):637–9.CrossRef Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement Jama. 1996;276(8):637–9.CrossRef
16.
Zurück zum Zitat Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.PubMedCrossRef Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.PubMedCrossRef
18.
Zurück zum Zitat Robien K, Demark-Wahnefried W, Rock CL. Evidence-based nutrition guidelines for cancer survivors: current guidelines, knowledge gaps, and future research directions. J Am Diet Assoc. 2011;111(3):368–75.PubMedCrossRef Robien K, Demark-Wahnefried W, Rock CL. Evidence-based nutrition guidelines for cancer survivors: current guidelines, knowledge gaps, and future research directions. J Am Diet Assoc. 2011;111(3):368–75.PubMedCrossRef
19.
Zurück zum Zitat Tew GA, Brabyn S, Cook L, Peckham E. The completeness of intervention descriptions in randomised trials of supervised exercise training in peripheral arterial disease. PLoS One. 2016;11(3):e0150869.PubMedPubMedCentralCrossRef Tew GA, Brabyn S, Cook L, Peckham E. The completeness of intervention descriptions in randomised trials of supervised exercise training in peripheral arterial disease. PLoS One. 2016;11(3):e0150869.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Abell B, Glasziou P, Hoffmann T. Reporting and replicating trials of exercise-based cardiac rehabilitation: do we know what the researchers actually did? Circulation Cardiovascular quality and outcomes. 2015;8(2):187–94.PubMedCrossRef Abell B, Glasziou P, Hoffmann T. Reporting and replicating trials of exercise-based cardiac rehabilitation: do we know what the researchers actually did? Circulation Cardiovascular quality and outcomes. 2015;8(2):187–94.PubMedCrossRef
21.
Zurück zum Zitat Candy B, Vickerstaff V, Jones L, King M. Description of complex interventions: analysis of changes in reporting in randomised trials since 2002. Trials. 2018;19(1):110.PubMedPubMedCentralCrossRef Candy B, Vickerstaff V, Jones L, King M. Description of complex interventions: analysis of changes in reporting in randomised trials since 2002. Trials. 2018;19(1):110.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.PubMedPubMedCentralCrossRef Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ Clinical research ed. 2010;340:c332.PubMedPubMedCentralCrossRef Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ Clinical research ed. 2010;340:c332.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295–309.PubMedCrossRef Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295–309.PubMedCrossRef
25.
Zurück zum Zitat Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.CrossRefPubMed Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.CrossRefPubMed
26.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Plos Med. 2009;6(7):e100010.PubMedPubMedCentralCrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Plos Med. 2009;6(7):e100010.PubMedPubMedCentralCrossRef
28.
30.
Zurück zum Zitat Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126–31.PubMedPubMedCentral Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126–31.PubMedPubMedCentral
31.
Zurück zum Zitat Wolin KY, Schwartz AL, Matthews CE, Courneya KS, Schmitz KH. Implementing the exercise guidelines for cancer survivors. The journal of supportive oncology. 2012;10(5):171–7.PubMedPubMedCentralCrossRef Wolin KY, Schwartz AL, Matthews CE, Courneya KS, Schmitz KH. Implementing the exercise guidelines for cancer survivors. The journal of supportive oncology. 2012;10(5):171–7.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Buffart LM, Galvao DA, Brug J, Chinapaw MJ, Newton RU. Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions. Cancer Treat Rev. 2014;40(2):327–40.PubMedCrossRef Buffart LM, Galvao DA, Brug J, Chinapaw MJ, Newton RU. Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions. Cancer Treat Rev. 2014;40(2):327–40.PubMedCrossRef
33.
Zurück zum Zitat Spence R, Heesch K, Brown W. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev. 2010;36(2):185–94.PubMedCrossRef Spence R, Heesch K, Brown W. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev. 2010;36(2):185–94.PubMedCrossRef
35.
Zurück zum Zitat Sakzewski L, Reedman S, Hoffmann T. Do we really know what they were testing? Incomplete reporting of interventions in randomised trials of upper limb therapies in unilateral cerebral palsy. Res Dev Disabil. 2016;59:417–27.PubMedCrossRef Sakzewski L, Reedman S, Hoffmann T. Do we really know what they were testing? Incomplete reporting of interventions in randomised trials of upper limb therapies in unilateral cerebral palsy. Res Dev Disabil. 2016;59:417–27.PubMedCrossRef
36.
Zurück zum Zitat Neil-Sztramko SE, Winters-Stone KM, Bland KA, Campbell KL. Updated systematic review of exercise studies in breast cancer survivors: attention to the principles of exercise training. Br J Sports Med. 2019;53(8):504–12.PubMedCrossRef Neil-Sztramko SE, Winters-Stone KM, Bland KA, Campbell KL. Updated systematic review of exercise studies in breast cancer survivors: attention to the principles of exercise training. Br J Sports Med. 2019;53(8):504–12.PubMedCrossRef
37.
Zurück zum Zitat Neil-Sztramko SE, Medysky ME, Campbell KL, Bland KA, Winters-Stone KM. Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review. BMC Cancer. 2019;19(1):321.PubMedPubMedCentralCrossRef Neil-Sztramko SE, Medysky ME, Campbell KL, Bland KA, Winters-Stone KM. Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review. BMC Cancer. 2019;19(1):321.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86–9.CrossRefPubMed Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86–9.CrossRefPubMed
39.
Zurück zum Zitat Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–76.PubMedCrossRef Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–76.PubMedCrossRef
40.
Zurück zum Zitat Slade SC, Dionne CE, Underwood M, Buchbinder R. Consensus on exercise reporting template (CERT): explanation and elaboration statement. Br J Sports Med. 2016;50(23):1428–37.PubMedCrossRef Slade SC, Dionne CE, Underwood M, Buchbinder R. Consensus on exercise reporting template (CERT): explanation and elaboration statement. Br J Sports Med. 2016;50(23):1428–37.PubMedCrossRef
41.
Zurück zum Zitat Mohler R, Kopke S, Meyer G. Criteria for reporting the development and evaluation of complex interventions in healthcare: revised guideline (CReDECI 2). Trials. 2015;16:204.PubMedPubMedCentralCrossRef Mohler R, Kopke S, Meyer G. Criteria for reporting the development and evaluation of complex interventions in healthcare: revised guideline (CReDECI 2). Trials. 2015;16:204.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ Clinical research ed. 2008;337:a1655 a.PubMedPubMedCentral Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ Clinical research ed. 2008;337:a1655 a.PubMedPubMedCentral
43.
Zurück zum Zitat Hopewell S, Ravaud P, Baron G. Boutron I. Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ : British Medical Journal. 2012;344:e4178.PubMedCrossRefPubMedCentral Hopewell S, Ravaud P, Baron G. Boutron I. Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ : British Medical Journal. 2012;344:e4178.PubMedCrossRefPubMedCentral
Metadaten
Titel
Analysis of reporting completeness in exercise cancer trials: a systematic review
verfasst von
Jose Francisco Meneses-Echavez
Indira Rodriguez-Prieto
Mark Elkins
Javier Martínez-Torres
Lien Nguyen
Julia Bidonde
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Medical Research Methodology / Ausgabe 1/2019
Elektronische ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-019-0871-0

Weitere Artikel der Ausgabe 1/2019

BMC Medical Research Methodology 1/2019 Zur Ausgabe